James Noble
Chairman chez OREXO AB
Fortune : 2 M $ au 31/03/2024
Profil
James Julian Noble founded Adaptimmune Ltd.
in 2008, where he worked as Chief Executive Officer from 2008 to 2014, Adaptimmune Therapeutics Plc in 2008, where he worked as Non-Executive Director from 2019 to 2023, and Immunocore Holdings Plc in 2008, where he worked as Non-Executive Director from 2014 to 2015.
Mr. Noble also currently works at Orexo AB, as Chairman from 2020, Celleron Therapeutics Ltd., as Chairman, Pneumagen Ltd., as Non-Executive Chairman from 2023, and various other companies.
Mr. Noble also formerly worked at Avidex Ltd., as Chairman & Chief Executive Officer from 2000 to 2014, AfriAg Global Plc, as Non-Executive Chairman from 2010 to 2012, GW Pharmaceuticals Ltd., as Deputy Chairman from 2007 to 2021, and various other companies.
Mr. Noble received his graduate degree in 1980 from the University of Oxford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/04/2023 | 8 145 700 ( 1,44% ) | 2 M $ | 31/03/2024 | |
OREXO AB
0,08% | 31/12/2022 | 28 000 ( 0,08% ) | 40 798 $ | 31/03/2024 |
Postes actifs de James Noble
| Sociétés | Poste | Début |
|---|---|---|
| LAVA THERAPEUTICS N.V. | Director/Board Member | 15/06/2022 |
| OREXO AB | Chairman | 16/04/2020 |
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Chairman | - |
Sutura Therapeutics Ltd.
 Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Chairman | - |
Pneumagen Ltd.
 Pneumagen Ltd. BiotechnologyHealth Technology Pneumagen Ltd. is engaged in biotechnology services. The company was founded in 2016 and is headquartered in Fife, the United Kingdom. | Chairman | 06/01/2023 |
Ingenox Therapeutics Ltd.
 Ingenox Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Ingenox Therapeutics Ltd. provides cancer treatment services. The private company is based in Oxford, UK. The CEO of the British company is Nick la Thangue. | Chairman | - |
| Pneumagen (Holdings) Ltd. | Director/Board Member | 01/01/2023 |
Anciens postes connus de James Noble
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Founder | 01/06/2023 |
| GW PHARMACEUTICALS PLC | Director/Board Member | 05/05/2021 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Formation de James Noble
| University of Oxford | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| STRATA SKIN SCIENCES, INC. | Health Technology |
| MEDIGENE AG | Health Technology |
| ADVANCED MEDICAL SOLUTIONS GROUP PLC | Health Technology |
| OREXO AB | Health Technology |
| LAVA THERAPEUTICS N.V. | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 31 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Anthra Pharmaceuticals, Inc.
 Anthra Pharmaceuticals, Inc. Medical DistributorsDistribution Services Anthra Pharmaceuticals, Inc. is an American company. | Distribution Services |
Albany Capital Plc
 Albany Capital Plc Financial ConglomeratesFinance Albany Capital plc is an activist and pre-IPO investment. It is a co-investor and principal alongside other institutions in private and listed companies using private equity techniques in order to achieve a medium term return. The company is headquartered in London, the United Kingdom. | Finance |
| Vestpa Plc | Finance |
Axellis, Inc.
 Axellis, Inc. Medical DistributorsDistribution Services Axellis, Inc. sells and distributes medical devices. Its products are used for oncology and cardiology. The company was founded in August 2007 and is headquartered in London, UK | Distribution Services |
Evolve Capital Plc
 Evolve Capital Plc Investment Trusts/Mutual FundsMiscellaneous Evolve Capital Plc operates as a closed-end investment fund/investment trust. Its principal activity is to invest in equities, convertible or non-convertible debt, options and warrants in companies which are quoted on intending to join, the PLUS-quoted market by way of an IPO. The company was founded on November 27, 2007 and is headquartered in London, the United Kingdom. | Miscellaneous |
AfriAg Global Plc
 AfriAg Global Plc Medical SpecialtiesHealth Technology AfriAg Global Plc engages in investing by seeking to acquire a direct and indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. It focuses on opportunities in Africa, Europe, and the Middle East. The company was founded on June 17, 2008 and is headquartered in London, the United Kingdom. | Health Technology |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Health Technology |
Finsbury Worldwide Pharmaceutical Trust Plc
 Finsbury Worldwide Pharmaceutical Trust Plc Investment Trusts/Mutual FundsMiscellaneous Finsbury Worldwide Pharmaceutical Trust Plc provides investment on pharmaceutical and biotechnology sector on a global scale. It reduces risk through extensive fundamental research, worldwide exposure, position limits and balanced market capitalisations. The company was founded in 1995 and is headquartered in London, the United Kingdom. | Miscellaneous |
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Astaire Group Ltd.
 Astaire Group Ltd. Investment Banks/BrokersFinance Astaire Group Ltd. provides investment banking services. The company was founded in 1984 and is headquartered in Colchester, the United Kingdom. | Finance |
| Astaire Securities Plc | Finance |
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Health Technology |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Commerzbank Finance Ltd.
 Commerzbank Finance Ltd. Investment Banks/BrokersFinance Part of Commerzbank AG, Commerzbank Finance Ltd. is a British company that provides securities brokerage services. The private company is based in London, UK. Commerzbank Finance was founded in 1955. | Finance |
| Prolifix Ltd. | Commercial Services |
Avidex Ltd.
 Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Health Technology |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Oxfordshire Biotechnet Ltd.
 Oxfordshire Biotechnet Ltd. Investment ManagersFinance Oxfordshire Biotechnet Ltd. is a venture capital fund. | Finance |
China Food Co. Plc
 China Food Co. Plc Food: Specialty/CandyConsumer Non-Durables China Food Co. Plc engaged in the development, manufacture and distribution of cooking and dipping sauces and animal feed products It offers consumer condiments such as soya sauce, vinegar, bean paste, pickled products, chilli oil, and flavour enhancers; and animal feeds such as compound feed, concentrate feed, and premix. The company was founded in November 1994 and was headquartered in London, the United Kingdom. | Consumer Non-Durables |
| Adprotech Pharmaceuticals, Inc. | |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Health Services |
Northland Capital Partners Ltd.
 Northland Capital Partners Ltd. Investment Banks/BrokersFinance Northland Capital Partners Ltd. provides investment banking services. The private company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 1991. Robert Alan Johnson has been the CEO of the company since 2010. | Finance |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Health Technology |
Pneumagen Ltd.
Pneumagen Ltd. BiotechnologyHealth Technology Pneumagen Ltd. is engaged in biotechnology services. The company was founded in 2016 and is headquartered in Fife, the United Kingdom. | Health Technology |
| Kleinwort Benson Ltd. (New York) | |
Sutura Therapeutics Ltd.
Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Commercial Services |
Ingenox Therapeutics Ltd.
Ingenox Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Ingenox Therapeutics Ltd. provides cancer treatment services. The private company is based in Oxford, UK. The CEO of the British company is Nick la Thangue. | Health Services |
| Pneumagen (Holdings) Ltd. |
